Within the same study, individuals with untreated T1D displayed significantly reduced blood glucagon levels and reduced blood glucose excursions after eight-weeks of exogenous insulin therapy when subjected to the same arginine infusion tests (21). The gene discussed is GCG; the disease is type 1 diabetes mellitus.